Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Market Cap	26.08B
Revenue (ttm)	3.94B
Net Income (ttm)	71.55M
Shares Out	23.39M
EPS (ttm)	3.05
PE Ratio	364.56
Forward PE	48.14
Dividend	1.00 (0.09%)
Ex-Dividend Date	Sep 6, 2024

Volume	103,628
Average Volume	350,433
Open	1,181.00
Previous Close	1,167.00
Day's Range	1,108.00 - 1,188.00
52-Week Range	621.00 - 1,232.75
Beta	0.21
RSI	63.12
Earnings Date	Jul 24, 2025

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical and agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. The company serves automotive, refinery, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1996
• Employees: 689
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TATVA

Financial Performance

In 2024, Tatva Chintan Pharma Chem's revenue was 3.83 billion, a decrease of -2.74% compared to the previous year's 3.94 billion. Earnings were 57.13 million, a decrease of -81.18%.